BioSpace News Archive

Genetown

Vertex and CRISPR Therapeutics Announce Acceptance of Late-Breaking Abstract for CTX001™ at the 2022 Annual European Hematology Association (EHA) Congress

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) today announced new late-breaking clinical data accepted for oral presentation at the 2022 European Hematology Association (EHA) Congress.

June 2, 2022
·
13 min read
Business

Specifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi

Specifica, a privately held antibody engineering company focused on innovative in vitro antibody libraries and discovery tools, today announced an agreement with the global healthcare company Sanofi under which Specifica’s patented Generation 3 Antibody Discovery Platform will be transferred to Sanofi.

June 2, 2022
·
2 min read
Rapid Medical Enrolls the First Patient in the DISTALS Stroke Trial–Offering Treatment to New Ischemic Stroke Patient Population

Rapid Medical, a leading developer of advanced neurovascular devices, announced today the enrollment of the first patient in the DISTALS Study.

June 2, 2022
·
2 min read
Infusion Pumps & Accessories Market Size to Surpass $13,264.18 Million by 2030

According to QY Research Medical, the infusion pumps & accessories market size is estimated to surpass around $13,264.18 Million by 2030 and growing at a CAGR of 5.2% from 2021 to 2030.

June 2, 2022
·
9 min read
Magnetic Resonance Imaging (MRI) Systems Market Size, Share, Growth, Report 2021 to 2030

According to QY Research Medical, the MRI Systems Market Size was estimated at US$ 5,772.48 million in 2020 and is expected to rake around $8,450.98 million by 2030, registering a CAGR of 4% from 2021 to 2030.

June 2, 2022
·
7 min read
Business

Concarlo Expands Executive Leadership Team with the Appointment of Dr. Krishna Allamneni as Chief Development Officer

Concarlo, a preclinical biotechnology company whose mission is to dramatically improve outcomes for patients with drug-resistant cancers by creating transformative therapies that control the p27 target, has appointed Dr. Krishna Allamneni as the Company’s Chief Development Officer.

June 2, 2022
·
3 min read
Policy

FDA Infant Formula Update: June 2, 2022

The U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities.

June 2, 2022
·
4 min read
Metabolomics Market Size to Reach $6,663 Million by 2030

The global metabolomics market size was accounted at $2,032 Million in 2020, and it is expected to reach $6,663 Million by 2030, registering a CAGR of 12.5% from 2021 to 2030.

June 2, 2022
·
8 min read
Nanomedicine Market Size, Share, Trends, Growth, Forecast Report 2021 to 2030

According to QY Research Medical, the nanomedicine market size was estimated at $171,695.33 million in 2020 and is expected to surpass $393,046.52 million by 2030, registering a CAGR of 9.5% from 2021 to 2030.

June 2, 2022
·
8 min read
Next Generation Diabetes Therapy and Drug Delivery Market Size, Report 2021 to 2030

The global Next Generation Diabetes Therapy and Drug Delivery Market size was reached at $7.1 billion in 2020, and is expected to hit $28.0 billion by 2030, growing at a CAGR of 14.28% from 2021 to 2030.

June 2, 2022
·
8 min read